Invasive mold infections in iatrogenically immunocompromised children: An eight-yr review

Pediatric Transplantation

Volumn 13, Issue 5, 2009, Pages 545-552

  Al Rezqi, Abdulkader ^a   Hawkes, Michael ^a   Doyle, John ^a   Richardson, Susan E ^a   Allen, Upton ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Cancer; Immunocompromised host; Invasive mold infection; Transplantation

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; ITRACONAZOLE; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ARTIFICIAL VENTILATION; ASPERGILLOSIS; ASPERGILLUS; CANCER PATIENT; CANDIDIASIS; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; INVASIVE MOLD INFECTION; LUNG INFECTION; LUNG MYCOSIS; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MONOTHERAPY; MORTALITY; MOULD; MYCOSIS; OPPORTUNISTIC INFECTION; ORGAN TRANSPLANTATION; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT OUTCOME;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; CHILD; FUNGI; GRAFT VS HOST DISEASE; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; LUNG TRANSPLANTATION; NEOPLASMS; RETROSPECTIVE STUDIES; RISK; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 67651177771     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.01056.x     Document Type: Article

References (40)

1. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002 : 34 : 909 917. (Pubitemid 34229758)
2. Burgos A, Zaoutis TE, Dvorak CC, et al. Pediatric invasive aspergillosis: A multicenter retrospective analysis of 139 contemporary cases. Pediatrics 2008 : 121 : e1286 e1294.
3. Segal BH, Almyroudis NG, Battiwalla M, et al. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts. Clin Infect Dis 2007 : 44 : 402 409.
4. Fukuda T, Boeckh M, Carter RA, et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 2003 : 102 : 827 833. (Pubitemid 36917771)
5. Nucci M, Marr KA, Queiroz-Telles F, et al. Fusarium infection in hematopoietic stem cell transplant recipients. Clin Infect Dis 2004 : 38 : 1237 1242.
6. Glockner A, Vehreschild JJ, Cornely OA. Zygomycosis - current epidemiological aspects. Mycoses 2007 : 50 (Suppl. 1 50 55.
7. Trifilio S, Verma A, Mehta J. Antimicrobial prophylaxis in hematopoietic stem cell transplant recipients: Heterogeneity of current clinical practice. Bone Marrow Transplant 2004 : 33 : 735 739.
8. Morgan J, Wannemuehler KA, Marr KA, et al. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: Interim results of a prospective multicenter surveillance program. Med Mycol 2005 : 43 (Suppl. 1 S49 S58.
9. Benjamin DK Jr., Miller WC, Bayliff S, Martel L, Alexander KA, Martin PL. Infections diagnosed in the first year after pediatric stem cell transplantation. Pediatr Infect Dis J 2002 : 21 : 227 234.
10. Hovi L, Saarinen-Pihkala UM, Vettenranta K, Saxen H. Invasive fungal infections in pediatric bone marrow transplant recipients: Single center experience of 10 years. Bone Marrow Transplant 2000 : 26 : 999 1004.
11. Minari A, Husni R, Avery RK, et al. The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants. Transpl Infect Dis 2002 : 4 : 195 200.
12. Walmsley S, Devi S, King S, Schneider R, Richardson S, Ford-Jones L. Invasive Aspergillus infections in a pediatric hospital: A ten-year review. Pediatr Infect Dis J 1993 : 12 : 673 682.
13. Wright JA, Bradfield SM, Park JR, Hawkins DS. Prolonged survival after invasive aspergillosis: A single-institution review of 11 cases. J Pediatr Hematol Oncol 2003 : 25 : 286 291.
14. Choi SS, Milmoe GJ, Dinndorf PA, Quinoneo RR. Invasive Aspergillus sinusitis in pediatric bone marrow transplant patients. Evaluation and management. Arch Otolaryngol Head Neck Surg 1995 : 121 : 1188 1192.
15. Wingard JR. The changing face of invasive fungal infections in hematopoietic cell transplant recipients. Curr Opin Oncol 2005 : 17 : 89 92.
16. Chamilos G, Marom EM, Lewis RE, Lionakis MS, Kontoyiannis DP. Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis 2005 : 41 : 60 66.
17. Fungal infections. Am J Transplant 2004 : 4 (Suppl. 10 110 134.
18. Gordon SM, Avery RK. Aspergillosis in lung transplantation: Incidence, risk factors, and prophylactic strategies. Transpl Infect Dis 2001 : 3 : 161 167.
19. Dummer JS, Lazariashvilli N, Barnes J, Ninan M, Milstone AP. A survey of anti-fungal management in lung transplantation. J Heart Lung Transplant 2004 : 23 : 1376 1381.
20. Shitrit D, Ollech JE, Ollech A, et al. Itraconazole prophylaxis in lung transplant recipients receiving tacrolimus (FK 506): Efficacy and drug interaction. J Heart Lung Transplant 2005 : 24 : 2148 2152.
21. Husain S, Paterson DL, Studer S, et al. Voriconazole prophylaxis in lung transplant recipients. Am J Transplant 2006 : 6 : 3008 3016. (Pubitemid 44777932)
22. Playford EG, Webster AC, Sorell TC, Craig JC. Antifungal agents for preventing fungal infections in solid organ transplant recipients. Cochrane Database Syst Rev 2004 : Issue 3 : CD004291.
23. Gabardi S, Kubiak DW, Chandraker AK, Tullius SG. Invasive fungal infections and antifungal therapies in solid organ transplant recipients. Transplant Int 2007 : 20 : 993 1015.
24. Robenshtok E, Gafter-Gvili A, Goldberg E, et al. Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: Systematic review and meta-analysis. J Clin Oncol 2007 : 25 : 5471 5489.
25. Ullmann AJ, Lipton JH, Vesole DH, et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007 : 356 : 335 347.
26. Cornely OA, Maertens J, Winston DJ, et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007 : 356 : 348 359.
27. Blyth CC, Palasanthiran P, O'Brien TA. Antifungal therapy in children with invasive fungal infections: A systematic review. Pediatrics 2007 : 119 : 772 784.
28. Patterson TF, Kirkpatrick WR, White M, et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore) 2000 : 79 : 250 260.
29. Cesaro S, Giacchino M, Locatelli F, et al. Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients. BMC Infect Dis 2007 : 7 : 28.
30. Cesaro S, Toffolutti T, Messina C, et al. Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis. Eur J Haematol 2004 : 73 : 50 55.
31. Merlin E, Galambrum C, Ribaud P, et al. Efficacy and safety of caspofungin therapy in children with invasive fungal infections. Pediatr Infect Dis J 2006 : 25 : 1186 1188.
32. Groll AH, Attarbaschi A, Schuster FR, et al. Treatment with caspofungin in immunocompromised paediatric patients: A multicentre survey. J Antimicrob Chemother 2006 : 57 : 527 535.
33. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002 : 347 : 408 415. (Pubitemid 34851833)
34. Cesaro S, Strugo L, Alaggio R, et al. Voriconazole for invasive aspergillosis in oncohematological patients: A single-center pediatric experience. Support Care Cancer 2003 : 11 : 722 727.
35. Goldstein B, Metlay L, Cox C, Rubinstein JS. Association of pre mortem diagnosis and autopsy findings in pediatric intensive care unit versus emergency department versus ward patients. Crit Care Med 1996 : 24 : 683 686.
36. Maris C, Martin B, Creteur J, et al. Comparison of clinical and post-mortem findings in intensive care unit patients. Virchows Arch 2007 : 450 : 329 333.
37. Cardoso MP, Bourguinon DC, Gomes MM, Saldiva PH, Pereira CR, Troster EJ. Comparison between clinical diagnoses and autopsy findings in a pediatric intensive care unit in Sao Paulo, Brazil. Pediatr Crit Care Med 2006 : 7 : 423 427.
38. Kaditis AG, Phadke S, Dickman P, Webber S, Kurland G, Michaels MG. Mortality after pediatric lung transplantation: Autopsies vs. clinical impression. Pediatr Pulmonol 2004 : 37 : 413 418.
39. Chamilos G, Luna M, Lewis RE, et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: An autopsy study over a 15-year period (1989-2003). Haematologica 2006 : 91 : 986 989.
40. Nucci M, Anaissie EJ, Quei-Telles F, et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer 2003 : 98 : 315 319.